Erlotinib vs Sitagliptin

Erlotinib vs Sitagliptin: Overview

This comparison examines the pharmacological differences between Erlotinib and Sitagliptin.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Sitagliptin: DPP-4 inhibitor increasing incretin levels.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Sitagliptin — 12.4 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Sitagliptin — C16H15F6N5O.

Molecular Weight: Erlotinib — 393.4380 g/mol; Sitagliptin — 407.3140 g/mol.

Type: Erlotinib — Small molecule; Sitagliptin — Small molecule.